Alzhemier's Research Trust Funding For Essex

Main Category: Alzheimer's / Dementia
Article Date: 01 Oct 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The Department of Biological Sciences at the University of Essex has received over £27,000 from the Alzheimer's Research Trust. Dr Jody Mason, a lecturer within the Department, will use this grant to undertake research regarding dementia patients.

Dr Mason explains: 'In neurodegenerative diseases such as Alzheimer's or Parkinson's, aggregation (or clumping) of proteins into toxic fibrils (or chains) is considered to be the key pathogenic event. However, no therapeutic agents currently exist to control this process. In particular, two proteins known as ß-amyloid and a-synuclein aggregate into fibrils, forming amyloid plaques and Lewy bodies that are characteristic of these diseases. A problem arises, however, in antagonist development; in recent years it has become established that small soluble (protofibrillar) forms of amyloid are the neurotoxic species, and that larger fibrils rather serve as reservoirs for these smaller protofibrils.'

'Unfortunately, peptides and drugs designed to prevent amyloid have until recently been concerned with removing these larger fibrillar deposits. If compounds designed to breakdown amyloid are only partially effective then the balance will be shifted in the direction of smaller protofibrillar forms, rendering the amyloid more toxic in the process. We will use our expertise in the amyloid, protein-protein interaction, and library screening and design fields to combat this.'

This grant application follows on from Dr Mason's previous experience in the field. There are currently 700,000 people living with dementia in the UK, this will rise to more than a million in less than 20 years. At present, dementia costs the UK around £17 billion each year. Development of drugs capable of slowing or stopping the onset of Alzheimer's or Parkinson's disease would improve the lives of millions of sufferers worldwide.

UNIVERSITY OF ESSEX
Wivenhoe Park
Colchester
CO4 3SQ
http:// www.essex.ac.uk

Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
UNIVERSITY OF ESSEX. "Alzhemier's Research Trust Funding For Essex." Medical News Today. MediLexicon, Intl., 1 Oct. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/123628.php>

APA
UNIVERSITY OF ESSEX. (2008, October 1). "Alzhemier's Research Trust Funding For Essex." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/123628.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »